Budesonide
NDC 54868-3550
Product Information
Budesonide is a ANDA-approved product labeled by Physicians Total Care, Inc.. Budesonide is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. It is supplied as a product. This product entry covers the primary NDC 54868-3550 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 54868-3550?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- BUDESONIDE (UNII: Q3OKS62Q6X)
- BUDESONIDE (UNII: Q3OKS62Q6X) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
- EDETATE DISODIUM (UNII: 7FLD91C86K)
- POLYSORBATE 80 (UNII: 6OZP39ZG8H)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 349094 - budesonide 0.25 MG in 2 ML Inhalation Suspension
- RxCUI: 349094 - budesonide 0.125 MG/ML Inhalation Suspension
- RxCUI: 349094 - budesonide 0.25 MG per 2 ML Inhalation Suspension
- RxCUI: 351109 - budesonide 0.5 MG in 2 ML Inhalation Suspension
- RxCUI: 351109 - budesonide 0.25 MG/ML Inhalation Suspension
* Please review the full disclaimer at the bottom of this page.